These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 15867028

  • 21. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD, Holtgrave DR, Pinkerton HJ.
    Arch Intern Med; 1997 Sep 22; 157(17):1972-80. PubMed ID: 9308509
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease.
    De Wals P, Nguyen VH, Erickson LJ, Guay M, Drapeau J, St-Laurent J.
    Vaccine; 2004 Mar 12; 22(9-10):1233-40. PubMed ID: 15003652
    [Abstract] [Full Text] [Related]

  • 23. Economic evaluation of pneumococcal conjugate vaccination in Finland.
    Salo H, Sintonen H, Nuorti JP, Linna M, Nohynek H, Verho J, Kilpi T.
    Scand J Infect Dis; 2005 Mar 12; 37(11-12):821-32. PubMed ID: 16308215
    [Abstract] [Full Text] [Related]

  • 24. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
    Platonov AE, Griffiths UK, Voeykova MV, Platonova OV, Shakhanina IL, Chistyakova GG, Robertson SE, Moscow Hib Study Team.
    Vaccine; 2006 Mar 20; 24(13):2367-76. PubMed ID: 16413949
    [Abstract] [Full Text] [Related]

  • 25. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model.
    Trotter CL, Edmunds WJ.
    Med Decis Making; 2006 Mar 20; 26(1):38-47. PubMed ID: 16495199
    [Abstract] [Full Text] [Related]

  • 26. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD, Sedyaningsih ER, Griffiths UK, Sutanto A, Linehan M, Mercer D, Mulholland EK, Walker DG, Steinhoff M, Nadjib M.
    Pediatr Infect Dis J; 2008 May 20; 27(5):438-43. PubMed ID: 18398383
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An economic analysis of the universal varicella vaccination program in the United States.
    Zhou F, Ortega-Sanchez IR, Guris D, Shefer A, Lieu T, Seward JF.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S156-64. PubMed ID: 18419391
    [Abstract] [Full Text] [Related]

  • 32. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.
    Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, Pondo T, Arnold KE, Baumbach J, Bennett N, Craig AS, Farley M, Gershman K, Petit S, Lynfield R, Reingold A, Schaffner W, Shutt KA, Zell ER, Mayer LW, Clark T, Stephens D, Messonnier NE.
    Clin Infect Dis; 2010 Jan 15; 50(2):184-91. PubMed ID: 20001736
    [Abstract] [Full Text] [Related]

  • 33. A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada.
    Lebel MH, Kellner JD, Ford-Jones EL, Hvidsten K, Wang EC, Ciuryla V, Arikian S, Casciano R.
    Clin Infect Dis; 2003 Feb 01; 36(3):259-68. PubMed ID: 12539065
    [Abstract] [Full Text] [Related]

  • 34. Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France.
    Lecocq H, Parent du Châtelet I, Taha MK, Lévy-Bruhl D, Dervaux B.
    Vaccine; 2016 Apr 27; 34(19):2240-50. PubMed ID: 27002504
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P, Chotivitayatarakorn P, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2010 Jan 27; 41(1):114-25. PubMed ID: 20578490
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA, Winston FK, Kallan MJ, Branas CC, Schwartz JS.
    Ambul Pediatr; 2008 Jan 27; 8(1):58-65. PubMed ID: 18191783
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.